Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Mini Reviews in Medicinal Chemistry
|
May 11, 2023
Anticancer Drug Discovery By Structure-Based Repositioning Approach
Dharti H Modh, Vithal M Kulkarni
Journal of Biomolecular Structure & Dynamics
|
March 23, 2022
Fibroblast growth factor receptor (FGFR) inhibitors as anticancer agents: 3D-QSAR, molecular docking and dynamics simulation studies of 1, 6-naphthyridines and pyridopyrimidines
Dharti H Modh, Siddharth J Modi, Hemant Deokar, et al.
Bioorganic Chemistry
|
May 22, 2026
Biphenyl sulfonylurea Analogs as novel antiangiogenic agents: A repositioning and molecular modelling strategy
Dharti H Modh, Mit Joshi, Bhoomika M Patel, et al.
Bioorganic & Medicinal Chemistry
|
July 25, 2003
3D-QSAR of N-myristoyltransferase inhibiting antifungal agents by CoMFA and CoMSIA methods
P Purushottamachar, Vithal M Kulkarni
Journal of Computer-Aided Molecular Design
|
October 5, 2002
3D-QSAR and molecular modeling of HIV-1 integrase inhibitors
Mahindra T Makhija, Vithal M Kulkarni
European Journal of Medicinal Chemistry
|
October 1, 2020
Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma
Siddharth J Modi, Vithal M Kulkarni
Bioorganic & Medicinal Chemistry
|
February 12, 2002
Molecular modeling of protein tyrosine phosphatase 1B (PTP 1B) inhibitors
V Sreenivasa Murthy, Vithal M Kulkarni
Bioorganic & Medicinal Chemistry
|
May 2, 2002
3D-QSAR CoMFA and CoMSIA on protein tyrosine phosphatase 1B inhibitors
V Sreenivasa Murthy, Vithal M Kulkarni
Journal of Medicinal Chemistry
|
October 3, 2003
Understanding the antitumor activity of novel hydroxysemicarbazide derivatives as ribonucleotide reductase inhibitors using CoMFA and CoMSIA
Anand V Raichurkar, Vithal M Kulkarni
Organic & Biomolecular Chemistry
|
August 22, 2003
A proposed model of Mycobacterium avium complex dihydrofolate reductase and its utility for drug design
Prashant S Kharkar, Vithal M Kulkarni
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Mini Reviews in Medicinal Chemistry
|
May 11, 2023
Anticancer Drug Discovery By Structure-Based Repositioning Approach
Dharti H Modh, Vithal M Kulkarni
Journal of Biomolecular Structure & Dynamics
|
March 23, 2022
Fibroblast growth factor receptor (FGFR) inhibitors as anticancer agents: 3D-QSAR, molecular docking and dynamics simulation studies of 1, 6-naphthyridines and pyridopyrimidines
Dharti H Modh, Siddharth J Modi, Hemant Deokar, et al.
Bioorganic Chemistry
|
May 22, 2026
Biphenyl sulfonylurea Analogs as novel antiangiogenic agents: A repositioning and molecular modelling strategy
Dharti H Modh, Mit Joshi, Bhoomika M Patel, et al.
Bioorganic & Medicinal Chemistry
|
July 25, 2003
3D-QSAR of N-myristoyltransferase inhibiting antifungal agents by CoMFA and CoMSIA methods
P Purushottamachar, Vithal M Kulkarni
Journal of Computer-Aided Molecular Design
|
October 5, 2002
3D-QSAR and molecular modeling of HIV-1 integrase inhibitors
Mahindra T Makhija, Vithal M Kulkarni
European Journal of Medicinal Chemistry
|
October 1, 2020
Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma
Siddharth J Modi, Vithal M Kulkarni
Bioorganic & Medicinal Chemistry
|
February 12, 2002
Molecular modeling of protein tyrosine phosphatase 1B (PTP 1B) inhibitors
V Sreenivasa Murthy, Vithal M Kulkarni
Bioorganic & Medicinal Chemistry
|
May 2, 2002
3D-QSAR CoMFA and CoMSIA on protein tyrosine phosphatase 1B inhibitors
V Sreenivasa Murthy, Vithal M Kulkarni
Journal of Medicinal Chemistry
|
October 3, 2003
Understanding the antitumor activity of novel hydroxysemicarbazide derivatives as ribonucleotide reductase inhibitors using CoMFA and CoMSIA
Anand V Raichurkar, Vithal M Kulkarni
Organic & Biomolecular Chemistry
|
August 22, 2003
A proposed model of Mycobacterium avium complex dihydrofolate reductase and its utility for drug design
Prashant S Kharkar, Vithal M Kulkarni
Page
of 3